2,037
Views
16
CrossRef citations to date
0
Altmetric
Clinical Research

Modified release paracetamol overdose: a prospective observational study (ATOM-3)

ORCID Icon, , , , & ORCID Icon
Pages 810-819 | Received 22 Nov 2017, Accepted 07 Feb 2018, Published online: 16 Feb 2018

References

  • Salmonson H, Sjöberg G, Brogren J. The standard treatment protocol for paracetamol poisoning may be inadequate following overdose with modified release formulation: a pharmacokinetic and clinical analysis of 53 cases. Clin Toxicol. 2018;56:63–68.
  • Pharmacovigilance Risk Assessment Committee: European Medicines Agency. Paracetamol-modified release: PRAC recommends modified-release paracetamol be removed from market. 2017. [cited 2017 Oct 11]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Paracetamol-modified_release/human_referral_prac_000062.jsp&mid=WC0b01ac05805c516f.
  • European Medicines Agency. Modified-release paracetamol-containing products to be suspended from EU market. Recommendation endorsed due to the difficulty in managing overdose. 2017. [cited 2017 Dec 28]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2017/12/WC500240441.pdf.
  • Chiew AL, Fountain JS, Graudins A, et al. Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2015;203:215–218.
  • Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ. 1979;2:1097–1100.
  • Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557–1562.
  • Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58:777–787.
  • Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
  • Bacon TH, Hole JG, North M, et al. Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee. Br J Clin Pharmacol. 2002;53:629–636.
  • Coulthard P, Hill CM, Frame JW, et al. Pain control with paracetamol from a sustained release formulation and a standard release formulation after third molar surgery: a randomised controlled trial. Br Dent J. 2001;191:319–324.
  • Graudins A. Overdose with modified-release paracetamol (Panadol Osteo®) presenting to a metropolitan emergency medicine network: a case series. Emerg Med Australas. 2014;26:398–402.
  • Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol. 2017;55:1055–1065.
  • Tan C, Graudins A. Comparative pharmacokinetics of panadol extend and immediate-release paracetamol in a simulated overdose model. Emerg Med Australas. 2006;18:398–403.
  • Hoegberg L, Refsgaardb F, Pedersenb S, et al. Potential pharmacobezoar formation of extended-release tablets and their dissolution: an in vitro study: abstracts 37th international congress of the European association of poisons centres and clinical toxicologists (EAPCCT) 16–19 May 2017, Basel, Switzerland. Clin Toxicol. 2017;55:371–544.
  • Juurlink DN. Activated charcoal for acute overdose: a reappraisal. Br J Clin Pharmacol. 2016;81:482–487.
  • Isbister GK, Kumar VV. Indications for single-dose activated charcoal administration in acute overdose. Curr Opin Crit Care. 2011;17:351–357.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.